Physician profile
Tracy Ford
NPI 1376925891
$1,272.77
in general payments reported to CMS, 2019-2025
8 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.02 · 2023: $325 · 2024: $496 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $546.51 | 2022-2025 | Puraply, Apligraf, Puraply Franchise |
| Kerecis Limited | $261.33 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $188.48 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Smith+Nephew, INC. | $121.17 | 2024-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Bioventus LLC | $58.82 | 2022-2023 | Sonicone Clinic |
| Tactile Systems Technology INC | $56.06 | 2024 | Flexitouch Plus, Entre Plus |
| Mimedx Group, INC. | $24.02 | 2025 | |
| Paratek Pharmaceuticals, INC. | $16.38 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.